Breast Cancer News

DPYSL3 an outlier gene in triple-negative breast cancerNov 26, 2018
Researchers have developed an entirely new therapeutic hypothesis on how to treat an aggressive form of triple-negative breast cancer.
Repurposing FDA-approved drugs to fight breast cancerNov 16, 2018
A team of researchers shows Food and Drug Administration (FDA)-approved compounds can stop cancer growth and can potentially lead to the discovery of drugs in a way that is quicker and less expensive than traditional drug development strategies.
Novel strategy may reduce breast cancer bone metastasisNov 12, 2018
Uncovering a novel mechanism that promotes growth of breast cancer bone metastasis has revealed a potential Achilles' heel for these cancer cells. 
Dr. Alastair Thompson to lead breast surgical oncologyOct 22, 2018
Dr. Alastair Thompson is bringing his expertise Baylor as the new section chief of breast surgery in the Michael E. DeBakey Department of Surgery, Division of Surgical Oncology, and co-director of the Lester and Sue Smith Breast Center.
Grant supports research into racial, ethnic health disparitiesOct 3, 2018
The National Cancer Institute has awarded $6.3 million dollars Baylor researchers to create new tools to help researchers to better understand the biological causes behind racial and ethnic health disparities in prostate and breast cancers.
Research leads to rare ER+ breast cancer mutations insightSep 4, 2018
Researchers conducted the largest analysis to date to establish associations between rare somatic mutations and prognosis in estrogen receptor positive (ER+) breast cancer
Estrogen receptor events linked to breast cancer metastasisAug 7, 2018
Researchers identify estrogen receptor alpha gene (ESR1) translocation events that drive not only therapeutic resistance, but also trigger ER+ breast cancer cells to metastasize.
Baylor launches community breast cancer education eventJun 27, 2018
Baylor College of Medicine has launched Breast Cancer Conversations, a quarterly educational event designed to inform the public about what’s new in breast cancer.
DNA repair defect may drive some cancer treatment resistanceMay 25, 2018
Researchers found that defects in selective DNA damage repair pathways can drive endocrine treatment resistance in a subset of estrogen receptor positive breast cancer patients.
Researchers awarded multiple Department of Defense grants in next frontier of breast cancer genomicsMay 24, 2018
The Department of Defense has awarded researchers at Baylor College of Medicine multiple grants to help better understand breast cancer genomics.